We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Sensus Healthcare, Inc. (SRTS) Dips More Than Broader Market: What You Should Know
Read MoreHide Full Article
Sensus Healthcare, Inc. (SRTS - Free Report) closed at $4.16 in the latest trading session, marking a -9.17% move from the prior day. This move lagged the S&P 500's daily loss of 0.33%. Elsewhere, the Dow lost 0.63%, while the tech-heavy Nasdaq lost 0.22%.
The company's stock has dropped by 7.85% in the past month, falling short of the Medical sector's loss of 0.32% and the S&P 500's gain of 4.07%.
The investment community will be closely monitoring the performance of Sensus Healthcare, Inc. in its forthcoming earnings report. The company's earnings per share (EPS) are projected to be $0.01, reflecting a 90% decrease from the same quarter last year. At the same time, our most recent consensus estimate is projecting a revenue of $8.8 million, reflecting a 4.76% fall from the equivalent quarter last year.
SRTS's full-year Zacks Consensus Estimates are calling for earnings of $0.11 per share and revenue of $41.95 million. These results would represent year-over-year changes of -73.17% and +0.34%, respectively.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Sensus Healthcare, Inc. Such recent modifications usually signify the changing landscape of near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Sensus Healthcare, Inc. is currently sporting a Zacks Rank of #5 (Strong Sell).
Looking at its valuation, Sensus Healthcare, Inc. is holding a Forward P/E ratio of 41.64. For comparison, its industry has an average Forward P/E of 23.76, which means Sensus Healthcare, Inc. is trading at a premium to the group.
The Medical - Instruments industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 168, finds itself in the bottom 32% echelons of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Sensus Healthcare, Inc. (SRTS) Dips More Than Broader Market: What You Should Know
Sensus Healthcare, Inc. (SRTS - Free Report) closed at $4.16 in the latest trading session, marking a -9.17% move from the prior day. This move lagged the S&P 500's daily loss of 0.33%. Elsewhere, the Dow lost 0.63%, while the tech-heavy Nasdaq lost 0.22%.
The company's stock has dropped by 7.85% in the past month, falling short of the Medical sector's loss of 0.32% and the S&P 500's gain of 4.07%.
The investment community will be closely monitoring the performance of Sensus Healthcare, Inc. in its forthcoming earnings report. The company's earnings per share (EPS) are projected to be $0.01, reflecting a 90% decrease from the same quarter last year. At the same time, our most recent consensus estimate is projecting a revenue of $8.8 million, reflecting a 4.76% fall from the equivalent quarter last year.
SRTS's full-year Zacks Consensus Estimates are calling for earnings of $0.11 per share and revenue of $41.95 million. These results would represent year-over-year changes of -73.17% and +0.34%, respectively.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Sensus Healthcare, Inc. Such recent modifications usually signify the changing landscape of near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Sensus Healthcare, Inc. is currently sporting a Zacks Rank of #5 (Strong Sell).
Looking at its valuation, Sensus Healthcare, Inc. is holding a Forward P/E ratio of 41.64. For comparison, its industry has an average Forward P/E of 23.76, which means Sensus Healthcare, Inc. is trading at a premium to the group.
The Medical - Instruments industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 168, finds itself in the bottom 32% echelons of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.